Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment

2016/04/03 by Mary Linton B. Peters, Jennifer F. Tseng, Rebecca A. Miksad · 21 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Bioinformatics #Biology #Cancer #Cancer Genomics and Diagnostics #Cancer research #Erlotinib #Gene #Genetic testing #Genetics #Germline #Germline mutation #Internal medicine #Medicine #Mutation #Oncology #PARP inhibitor #Pancreatic and Hepatic Oncology Research #Pancreatic cancer #Pancreatitis Pathology and Treatment #Personalized medicine #Polymerase

paper · pdf · doi:10.1016/j.clinthera.2016.03.006

published in Clinical Therapeutics 38(7), 1622-1635 (Elsevier BV)

openalex publication_date 2016/04/03 · crossref created 2016/04/03 · crossref issued 2016/07/01 · crossref published 2016/07/01 · crossref published-print 2016/07/01 · crossref deposited 2024/06/15 · openalex created_date 2025/10/10 · crossref indexed 2026/03/03 · openalex updated_date 2026/07/29

Citations

• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
• Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
• Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: Correlation of genotype to phenotype
• Metastatic Colorectal Cancer: Current State and Future Directions
• Somatic mutation in cancer and normal cells
• DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Cited by

• Pancreatic cancer [wikipedia]